6月28日上午,港股三叶草生物涨超48%,三叶草生物公告称,新冠候选疫苗作为同源加强针显示出对奥密克戎的强烈交叉中和作用。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.